Resource Details
Resource Sections
Errors / Omissions?

Do you see an error or want to contribute? Please contact us, or register and submit your links.

Mailing List
Subscribe to our newsletter and receive regular updates on new features, new policy areas, announcements, and more.

HomePolicy Articles Article Summary

Brief to the House of Commons Standing Committee on Health Study on Prescription Drugs

Briefing by John Graham

This brief report by John Graham provides an overview of key points pertaining to the issue of prescription drugs in Canada. Graham’s briefing was provided to the House of Commons Standing Committee on Health: Study on Prescription Drugs on behalf of the Fraser Institute. Graham suggests mechanisms for reviewing and controlling the prices of all prescription drugs, mechanisms for approving new drugs and introducing them to the market, and provides international comparisons from which Canada can learn.

Among the specific topics that Graham addresses in his paper: amending the Canada Health Act to allow patients to spend money directly on all health services; lowering the barriers for entry into Canada’s generic pharmaceutical market; de-regulating direct-to-consumer advertising; and, stopping the illegal trade in prescription drugs from Canada to the United States.

(Added: Sun Feb 19 2006 Hits: 180 Rating: 0.00 Votes: 0)   Rate It   Review It

Policy Publication Details

Author(s): John Graham;
Publisher: Fraser Institute [ Visit Website ]
Year Published: 2003; Publisher Type: Research Institute
Publicly Available: Yes Research Focus: National;
Registration Required: No Language: English
Payment Required: No Publication Format: Adobe PDF

Subjects / Categories:

Policy Articles / Health Care
Policy Articles / Health Care / Pharmaceutical
Policy Articles / Health Care / Pharmaceutical / 2003

Keywords / Tags:

pharmaceuticals; prescription drugs; drug prices; drug regulations; drug control; approval of new drugs; public spending;